Fig. 1From: The long pentraxin PTX3: a novel serum marker to improve the prediction of osteoporosis and osteoarthritis bone-related phenotypesPTX3 serum levels in OP and OA patients compared to CTR subjects. OP and OA patients showed significantly higher mean circulating PTX3 level than CTR subjects (4.62 ± 1.78 ng/ml, 4.22 ± 1.06 ng/ml and 2.77 ± 0.42 ng/ml). **** P < 0.0001Back to article page